CUMC COVID-19 SYMPOSIa summaries
Characterizing and isolating antibodies from convalescent patients |
Diagnostics, therapeutics and social engagement at the Mailman School of Public Health
|
Targeting Master Regulators of coronavirus infection |
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase |
Building Biorepositories from Scratch in the Midst of a Crisis |
Effects of SARS-CoV-2 on Alveolar Epithelial Cells and Macrophages |
Experimental and computational interrogation of CoV protein functions |
International observational research on COVID-19 |
Scaling up for Surge Capacity and COVID-19 Patient tracking in the EHR: Leveraging Healthcare process modeling |
In vitro and In vivo models to study SARS-Cov2 infection |
Recombination and lineage-specific mutations led to the emergence of SARS-CoV-2 |
Entry inhibitor peptides for SARS-CoV-2 |
Transcriptional inhibition of viral entry proteins as a therapeutic strategy SARS CoV 2 |
Viral modeling using hPSC-derived lung organoidsHans Snoeck, MD, PhD
CHECK IT OUT > |
CovidWatcher: a citizen-science platform for tracking impact of the pandemic |
Multiplexed antiviral drug discovery |
Fecal shedding in COVID-19 patients and function of SARS-CoV-2 nsp4 and ORF8 proteins |